Ranbaxy launches generic versions of Atorvastatin in Italy, Sweden and the Netherlands
Pharmaceuticals major Ranbaxy Laboratories today said it had launched the generic versions of Atorvastatin tablets, 10mg, 20 mg, 40mg and 80mg in Italy and Sweden and 10mg, 20mg and 40mg in the Netherlands, after receiving approval from the respective local regulatory authorities.
Ranbaxy Pharmaceuticals has halted productions of its generic version of the cholesterol drug Lipitor after recalling a second batch of tablets in the 10mg, 20mg, and 40mg dosage strengths.